Haiyan Xu
11PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Sep 23, 2023
Pyrotinib plus antiangiogenic agents for HER2-altered advanced non-small cell lung cancer: A retrospective real-world study.Yaning Yang, Guangjian Yang, Weihua Li
|Jul 05, 2023
Influence of PD-L1 expression on the efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer.Si-Yu Lei, Hai-Yan Xu, Hong-Shuai Li
|Oct 11, 2022
Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice.Yaning Yang, Xin Ai, Haiyan Xu
|Sep 14, 2022
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity-matched analysis in a cohort of 147 recurrences.Fei Xu, Heng-Chi Chen, Haiyan Xu
|Dec 16, 2020
Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery.Lu Yang, Chong Pang, Fei Xu
|Oct 19, 2020
Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIs.Lu Yang, Xuezhi Hao, Xingsheng Hu
Pageof 2
